
Teleflex Incorporated TFX
$ 120.15
1.46%
Annual report 2025
added 02-27-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
44.6 M |
Market Cap[1] |
$ 5.36 B |
EBITDA (LTM) |
$ 301 M |
P/E (LTM) |
-58.9 |
P/S (LTM) |
1.67 |
EPS (LTM) |
-2.01 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 28.09 | -0.5 % | $ 1.34 B | Nasdaq Global Market,SPB | ||
|
Baxter International
BAX
|
$ 16.89 | -1.49 % | $ 8.66 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.72 | -0.1 % | $ 908 M | Nasdaq Global Select Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Haemonetics Corporation
HAE
|
$ 56.97 | -0.58 % | $ 2.87 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 77.86 | -0.19 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 8.95 | -0.78 % | $ 21.7 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 70.59 | -0.87 % | $ 14.1 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.2 | -0.36 % | $ 194 M | Nasdaq Capital Market | ||
|
Microbot Medical
MBOT
|
$ 2.28 | -12.16 % | $ 104 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 4.77 | 10.67 % | $ 212 M | Nasdaq Global Market | ||
|
electroCore
ECOR
|
$ 6.02 | -0.99 % | $ 51.1 K | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.31 | -0.01 % | $ 9.5 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 115.06 | -0.16 % | $ 3.68 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | -0.51 % | $ 23 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 68.34 | 0.12 % | $ 4.04 B | Nasdaq Global Select Market,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 116.4 | -0.05 % | $ 5.64 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 122.91 | -2.21 % | $ 3.03 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.38 | - | $ 194 M | NYSE American | ||
|
Retractable Technologies
RVP
|
$ 0.67 | -1.53 % | $ 20.1 M | NYSE American | ||
|
Envista Holdings Corporation
NVST
|
$ 26.27 | -0.49 % | $ 4.41 B | NYSE | ||
|
STERIS plc
STE
|
$ 221.88 | -0.3 % | $ 21.9 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 51.48 | - | $ 169 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 451.62 | 0.22 % | $ 161 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 65.9 | - | $ 214 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.66 | 0.03 % | $ 2.6 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.54 | -1.45 % | $ 2.3 B | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 227.94 | -0.34 % | $ 33.3 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 18.4 | -1.45 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.86 | -0.27 % | $ 169 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.16 | -1.06 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 257.52 | 0.39 % | $ 18.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 9.85 | 0.46 % | $ 402 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 153.57 | -0.37 % | $ 44.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.99 | 1.01 % | $ 31.1 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 2.97 | 0.17 % | $ 218 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 120.1 | - | $ 6.69 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.